MARTHA PAUL
No ORCID on file
· 98 papers in corpus
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…
2005
The invention provides a method of alleviating a sign or symptom of endometriois in a subject, by administering to the subject a composition containing a compound which inhibits angiogenisis, inflammation or matrix metalloproteinase express…